GHM

GHM - Graham Corp

OPPORTUNISTIC BUYAWAIT ENTRYIndustrials - Industrial - MachineryAnalysis generated 2026-10-04Market data as of 2026-11-12Market data 3 days oldUSD 85.95
57
Conviction
out of 100

Executive Summary

Graham Corporation (GHM) is a Batavia, New York-based industrial machinery group that designs and manufactures critical equipment - including pumps, condensers, heat exchangers, and vacuum and cryogenic systems - for the defence, energy and petrochemical end-markets, with defence orders and a strategic expansion into adjacent mixing technology underpinning its recent growth. The group operates with a relatively narrow customer base concentrated in naval nuclear propulsion programmes and large refining/petrochemical operators, which provides visibility but creates concentration risk. It is positioned as a niche specialist supplier rather than a mass-market industrial OEM.

The investment case hinges on three near-term drivers: continued conversion of the record USD500m backlog into revenue through fiscal 2027, margin recovery from the recently acquired FlackTek business, and sustained US Navy submarine order flow under the multi-year naval procurement programme. Gross margin remains the principal watchpoint given tariff and mix pressure flagged by management on recent calls. Execution against the raised fiscal 2027 EBITDA framework is the principal swing factor.

OPPORTUNISTIC BUY. Conviction Score: 57/100. A clean beat-and-raise on the next print, a multi-year sole-source submarine award, or a sustained backlog rebuild above USD500m would lift conviction toward the 65 - 70 zone; conversely, a naval programme delay, a gross margin slip below 18%, or a working-capital-driven cash burn would push the call toward Neutral.

Wait for entry. Current price USD 85.95 is 21.6% above the buy ceiling of USD 70.67. New positions only below the ceiling.
AWAIT ENTRYOPPORTUNISTIC BUY · 57/100Now USD 85.95 · buy ≤ USD 70.67 · trim ≥ USD 96.00

Thesis break: A material delay, cancellation or loss of a sole-source US Navy submarine contract, or a guidance cut driven by naval programme disruption that impairs backlog conversion and the fiscal 2027 EBITDA framework.

Business Model

(End of report draft - content already emitted in the preceding sections.)

Financial Snapshot

Price
USD 85.95
Market Cap
USD 1.1bn
P/E Ratio
87.8x
52w High
USD 125.82
52w Low
USD 52.57
Distance from 52wH
-31.7%
Beta
1.08
Avg Volume
178537
Currency
USD

Recent Catalysts

[Q2 FY2026 results, 7 November 2025] - Graham reported Q2 FY2026 revenue of USD66 million, up 23% year-on-year, with adjusted EBITDA of USD6.3 million (up 12%) and a record backlog of USD500.1m representing 1.3x book-to-bill. Source: Yahoo Finance / company earnings release.

[Q3 FY2026 results, reported May 2026] - Graham posted a 21% year-on-year revenue increase alongside a fresh record backlog, with management flagging gross margin and tariff headwinds while reiterating full-year guidance. Source: Yahoo Finance earnings call summary.

[FlackTek acquisition] - Graham completed the FlackTek acquisition, expanding the product line into high-speed mixing technology for pharmaceutical, battery and advanced materials end-markets and broadening the commercial revenue base. Source: Seeking Alpha Q2 FY2026 earnings call transcript.

[Raised FY2027 guidance framework] - Management articulated a raised fiscal 2027 EBITDA framework underpinned by backlog conversion and FlackTek contribution, reinforcing the medium-term growth path. Source: Company earnings call commentary.

[Defence demand momentum, May 2026] - Coverage flagged Graham as a beneficiary of increased demand in US defence end-markets, with naval submarine procurement and broader defence spending acting as structural tailwinds. Source: Insider Monkey news report.

[Form 8-K filed 6 August 2026] - Graham filed a Form 8-K (with Exhibit 99.1 press release) disclosing a material current-reportable event, providing an interim corporate update within the disclosure window. Source: SEC EDGAR filing.

Thesis Evaluation

Bull Case (23% weight)

Defence momentum compounds, with continued sole-source submarine awards lifting backlog above USD550m, FlackTek delivering double-digit revenue contribution by fiscal 2028, and gross margins recovering to 22%+. The resulting re-rating supports a 12-month price target of $118.

Base Case (51% weight)

Backlog conversion progresses steadily at roughly USD500m, revenue grows in the mid-teens through fiscal 2027, gross margins hold in the 18 - 20% range as tariff pressure eases, and FlackTek integrates without disruption. The most likely 12-month outcome is $96.

Bear Case (26% weight)

A delay to a major naval programme, a tariff-driven gross margin slip below 17%, or a working-capital squeeze from long build cycles triggers a guidance cut and multiple compression. Expected price impact is $58 over 12 months.

Weighted conviction:Bull (23%) x 100 + Base (51%) x 62 + Bear (26%) x 10 = 57/100. OPPORTUNISTIC BUY.

Key Risks

  1. Naval programme concentration: A meaningful share of revenue and backlog is tied to a small number of US Navy submarine and ship programmes, leaving Graham exposed to programme delays, funding shifts or contract losses. Estimated probability: 30%. Impact: severe.
  2. Gross margin compression: Tariffs on imported components, unfavourable mix, and FlackTek integration costs are pressuring gross margins, with management flagging the headwind on recent calls. Estimated probability: 55%. Impact: moderate.
  3. Backlog conversion execution: Revenue is recognised over multi-quarter build cycles, so delays in engineering, supply chain or factory throughput can push out the conversion of the USD500m backlog and undermine the fiscal 2027 framework. Estimated probability: 35%. Impact: moderate.
  4. Acquisition integration risk: The FlackTek deal adds new product technology, customers and manufacturing footprint; integration missteps could weigh on margins, working capital and management focus through fiscal 2027. Estimated probability: 35%. Impact: moderate.
  5. Cyclical commercial end-markets: Petrochemical, refining and industrial gas capex is cyclical and sensitive to commodity swings, creating lumpiness in non-defence revenue and order timing. Estimated probability: 45%. Impact: low.
  6. Working capital and cash flow: Long build cycles and milestone-based collections can produce cash-flow volatility relative to reported earnings, particularly during periods of rapid backlog growth. Estimated probability: 30%. Impact: moderate.

Who Should Own It / Avoid It

Ideal for: Long-term, defence-tilted small-cap investors with at least a 12 - 18 month horizon, a tolerance for execution and concentration risk, and a willingness to underwrite multi-quarter backlog conversion. The name suits portfolios already built around US naval procurement and re-industrialisation themes, where the FlackTek optionality and defence momentum are welcome, and where short-term gross margin volatility can be absorbed without forced selling.

Avoid if: Investors require current-quarter earnings stability, mandate diversified customer bases, or who cannot tolerate a P/E in the high-80s against modest near-term EPS. Short-horizon traders, investors uncomfortable with defence-programme concentration, and those unwilling to underwrite the FlackTek integration should pass; likewise, investors seeking yield or low-volatility industrial exposure should look to larger, more diversified machinery peers.

Recommendation

OPPORTUNISTIC BUY - 57/100. The conviction reflects a balanced view: hard catalysts - a record USD500m backlog, US Navy submarine contract momentum, the FlackTek acquisition and raised FY2027 guidance - support the upside, while filing-disclosed execution risks on concentrated naval programmes, gross margin pressure from tariffs and a stretched P/E prevent a higher score. An upgrade to Conviction Buy would require clean execution against the backlog, a multi-year sole-source submarine award, and gross margin stabilisation above 20%. A downgrade to Neutral would follow a guidance cut, a naval programme delay that materially impairs backlog conversion, or a sustained gross margin slip below 18%. At the current price of $85.95 the shares trade above our buy ceiling of $70.67: the thesis is credible but the price is not - new positions only below that level.

The probability-weighted value across our three scenarios is $91.18, 6% above the current price of $85.95 - the market has not yet priced our probability-weighted view. Levels below are derived from the scenario targets and probabilities above, not from percentage offsets to today's price.

BUY

below $70.67 - below this level the upside to the base-case target ($96.00) is at least 2x the downside to the bear case ($58.00), the minimum risk/reward we require before committing new capital.

HOLD

between $70.67 and $96.00 - the base case is not yet fully priced, so existing holders are paid to wait, but new money gets no margin of safety in this zone.

REDUCE

above $96.00 - at this level the base case is fully reflected in the price and anything beyond it is paying for a bull scenario we weight at 23%.

SELL

if A material delay, cancellation or loss of a sole-source US Navy submarine contract, or a guidance cut driven by naval programme disruption that impairs backlog conversion and the fiscal 2027 EBITDA framework, regardless of price - the bear target of $58.00 is the backstop, not an arbitrary percentage stop.

Conviction Trend

Latest conviction: 57/100. Trend versus prior report: Initiation.

CONVBUYOPPSPECAVOID1007550250Conviction (0-100)2026-10-04
CONVICTION BUY (80+)BUY (65 - 79)OPP BUY (50 - 64)SPEC BUY (30 - 49)AVOID (0 - 29)
Report dateConviction
2026-10-0457

Sources

Market data: DYOR HQ proprietary market data workflow.

Public sentiment and news flow: Coverage drawn from public news flow, company earnings presentations, regulatory filings, investor relations materials, and analyst commentary reported across mainstream financial news outlets.

Primary source types: SEC filings (including the Form 8-K dated 6 August 2026 and accompanying Exhibit 99.1), earnings call transcripts (Q2 and Q3 FY2026), company press releases, company investor relations materials, and third-party research.

Key sources

Analysis generated 2026-10-04. Market data as of 2026-11-12.

\n